{
    "url_original": "https://www.wsj.com/articles/cdc-backs-pfizer-biontech-booster-for-immunocompromised-children-11641314181?mod=business_lead_pos2",
    "url": "cdc-backs-pfizer-biontech-booster-for-immunocompromised-children-11641314181",
    "title": "CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children",
    "sub_head": "Agency recommends extra dose for children 5 to 11 years who are moderately or severely immunocompromised",
    "category_1": "Business",
    "category_2": "Health Care",
    "time": "2022-01-04 11:36:00",
    "body": "The Centers for Disease Control and Prevention recommended that many children with weakened immune systems get a booster from  Pfizer Inc.  and  BioNTech SE  four weeks after their second shot.<br />The agency issued the recommendation Tuesday for moderately and severely immunocompromised children 5 to 11 years."
}